Status:
RECRUITING
Memory Enhancement Using Transcranial Alternating Current Stimulation
Lead Sponsor:
Amsterdam UMC, location VUmc
Conditions:
Alzheimer Disease
Mild Cognitive Impairment
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The 32 million Alzheimer's disease (AD) and 69 million prodromal AD patients worldwide contribute to a large economic burden. Effective and safe therapies that slow or prevent the progression from mil...
Eligibility Criteria
Inclusion
- Recent (not more than 6 months ago) amnestic MCI diagnosis, which consensus is obtained in a multidisciplinary meeting after an extended multidisciplinary test battery at the memory clinic, including confirmation of AD pathology with cerebrospinal fluid biomarkers: abnormal p-tau/Aβ42 ratio of \> 0.023
Exclusion
- Suffering from serious neurological, psychiatric or somatic comorbidity
- Suffering from epileptic seizures or severe claustrophobia
- Intensive use of psychoactive medication
- Having a cardiac pacemaker, internal cardiac defibrillator or other intracorporeal device that interferes with MEG recordings
Key Trial Info
Start Date :
November 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT06202872
Start Date
November 15 2024
End Date
February 1 2026
Last Update
December 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amsterdam UMC, The Netherlands
Amsterdam, North Holland, Netherlands, 1081HV